HMGB3 and non-small cell lung carcinoma: The poor prognosis for patients with NSCLC with high rates of HMGB3 expression may be due to increased glycolysis under hypoxic conditions, which is provided by the activity of miR-615-3p/HMGB3 signaling axis.